Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure

JACC Heart Failure(2021)10.1016/j.jchf.2020.12.015Source: DataRank Database

Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure is a research paper published in JACC Heart Failure (2021). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 3.21)OA: bronzeTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Wouter Ouwerkerk ORCID,John G.F. Cleland ORCID,Christiane E. Angermann ORCID,Ulf Dahlström ORCID,Tiew‐Hwa Katherine Teng ORCID

Live enrichment

PubMed:33839078 OpenAlex:https://openalex.org/W3149831127

Abbott Laboratories

AstraZeneca

Boehringer Ingelheim

National Institutes of Health

Amgen

Medtronic

Roche

Sanofi

Bundesministerium für Bildung und Forschung

Philips

Vifor Pharma

Agency for Healthcare Research and Quality

Boston Scientific Corporation

MyoKardia

Servier

Bristol-Myers Squibb

European Commission

Bayer

National Medical Research Council

American Heart Association

Novartis

Patient-Centered Outcomes Research Institute

Pfizer

FWCI

3.21

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S2213177921000548/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2213177921000548/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213177921000548?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213177921000548?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jchf.2020.12.015

Fields of Study

Heart Failure Treatment and ManagementAcute Myocardial Infarction ResearchCardiovascular Function and Risk Factors

MeSH Terms

Heart FailureHospitalizationHumansPrognosisRegistriesStroke VolumeVentricular Function, LeftMyocardial Ischemia

Keywords

MedicineEjection fractionHeart failureHazard ratioInternal medicineCardiologyCoronary artery diseaseRevascularizationConfidence intervalMyocardial infarctionOutcomesEvidence-based PharmacotherapyIschemic heart Disease

Sustainable Development Goals

SDG 0: No poverty